Literature DB >> 750205

99mTc-diethyl-HIDA: a contribution to the study of its structure.

U Fonda, B Pedersen.   

Abstract

Sephadex column chromatography has shown that 99mTc-diethyl-HIDA consists of two clearly separable components. One of them seems to be an intermediate compound changing into the other, almost completely within two hours after reconstitution of the diethyl-HIDA (Solco HIDA) with pertechnetate. The two components could be the mono- and biscomplex of N-(2,6-diethyl-acetanilid)-imino diacetic acid with one atom of technetium. Animal experiments show that there is no important difference in the biological distribution in mice between the two components.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 750205     DOI： 10.1007/bf00251629

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  7 in total

1.  Why do Tc-99m chelates work for cholescintigraphy?

Authors:  G Firnau
Journal:  Eur J Nucl Med       Date:  1976-08-12

2.  Bile and urine as complementary pathways for the excretion of foreign organic compounds.

Authors:  P C Hirom; P Millburn; R L Smith
Journal:  Xenobiotica       Date:  1976-01       Impact factor: 1.908

3.  Technetium 99m-pyridoxylideneglutamate: a new hepatobiliary radiopharmaceutical. I. Experimental aspects.

Authors:  R J Baker; J C Bellen; P M Ronai
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

4.  An evaluation of 99mTc-labeled hepatobiliary agents.

Authors:  B W Wistow; G Subramanian; R L Heertum; R W Henderson; G M Gagne; R C Hall; J G McAfee
Journal:  J Nucl Med       Date:  1977-05       Impact factor: 10.057

5.  A possible artifact in gel chromatography of some 99m Tc-chelates.

Authors:  P E Valk; C A Dilts; J McRae
Journal:  J Nucl Med       Date:  1973-04       Impact factor: 10.057

6.  Chemical state of 99mTc in biomedical products.

Authors:  W Eckelman; G Meinken; P Richards
Journal:  J Nucl Med       Date:  1971-09       Impact factor: 10.057

7.  Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid.

Authors:  M D Loberg; M Cooper; E Harvey; P Callery; W Faith
Journal:  J Nucl Med       Date:  1976-07       Impact factor: 10.057
  7 in total
  4 in total

1.  Quality control of 99mTc-radiopharmaceuticals. Evaluation of GCS minicolumns in routine clinical work with scintillation cameras.

Authors:  L Darte; B R Persson
Journal:  Eur J Nucl Med       Date:  1980-12

2.  Composition of 99mTc-HIDA as a function of time after kit preparation.

Authors:  R W Nicholson; K J Herman; R A Shields; H J Testa
Journal:  Eur J Nucl Med       Date:  1982

3.  The stability of 99mTc-DTPA and 99mTc-HIDA following ultrasonic nebulisation.

Authors:  N Durovic; M Pillay; P H Cox
Journal:  Eur J Nucl Med       Date:  1988

4.  The preparation and composition of HIDA.

Authors:  R W Nicholson; K J Herman; R A Shields; H J Testa
Journal:  Eur J Nucl Med       Date:  1980-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.